Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: ARO-APOC3
Total 0 results
Nothing found
Sponsors and Collaborators
YASEMİN AYDIN KARTAL
Phramongkutklao College of Medicine and Hospital
Axon Neuroscience SE
Invicta Medical Inc.
Aga Khan Foundation, Pakistan
EMET Pharmaceuticals, LLC
Doterra Healing Hands Foundation
Erzurum Regional Training & Research Hospital
Yancheng City NO.1 People's Hospital
Eastman Kodak Company
CeRSM
CARITAS Rundum zu Hause betreut
Alessandra Palo
Sichuan Haisco Pharmaceutical Group Co., Ltd
Saint Pierre Institute - Palavas les Flots
Grünenthal Denmark ApS
Irish Endocrine Society
Outpatient Endovascular and Interventional Society
Gregorio Covino
Department of Anesthesiology, North Denmark Regional Hospital
View Full List
Medical Conditions
Neutrophilia Acute
Mineralocorticoid Excess
Osteopathic Manipulative Treatment
Pelvic and Groin Areas Biopsy
Bioequivalence, AUC, Cmax, Pharmacokinetics
Abdominal Compartment Syndrome
Acute Endophthalmitis Post-operative
Reading Disability
Venous Puncture
Hemopathies
Modality of Discharge Instructions
Chondrosis
Pharmacokinetics of Plasma Phenolic Glucuronide of MPA (MPAG)
Skeletal Muscle Energy Metabolism
Hypogonadism, Hypogonadotropic
Major Depressive Disorder, Recurrent Episode, Severe
Human Risk Factors
Ferritin Threshold
HIV Pre-exposure Prophylaxis Use
Central Motor Disorders
View Full List
Drug Interventions
MYL-1501D product using manufacture process VI
Anti-PD1 antibody, nimotuzumab and capecitabine
Pregabalin
Enteral oxygen therapy
Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen
LY2216684
Betamethasone
Ranitidine
Niraparib
Naltrexone 50 Mg + Inactive Marijuana (0% THC)
Neridronate
Amantadine Sulfate
Pacritinib
Lenalidomide
Apatinib
Leuprolide acetate 11.25 mg
Risperidone
Carbetocin
Systemic intravenous lidocaine infusion
Test varnish
View Full List
CROs by country
Contract Research Organizations in Belarus
Contract Research Organizations in Bulgaria
Contract Research Organizations in Gabon
Contract Research Organizations in Guatemala
Contract Research Organizations in Kazakhstan
Contract Research Organizations in Kuwait
Contract Research Organizations in Lebanon
Contract Research Organizations in Malta
Contract Research Organizations in Nigeria
Contract Research Organizations in Russia
Contract Research Organizations in Singapore
Contract Research Organizations in Suriname
Contract Research Organizations in Ukraine
CRO list by country
CROs in Ethiopia
SGS
All CROs in Ethiopia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe